Showing results (171-180 of 292) with videos related to
Sort By:
Pageof 30
Translational Psychiatry|April 12, 2018
CXCR4 involvement in neurodegenerative diseasesLuke W Bonham, Celeste M Karch, Chun C Fan, et al.Nature Communications|January 23, 2024
Human whole-exome genotype data for Alzheimer's diseaseYuk Yee Leung, Adam C Naj, Yi-Fan Chou, et al.Nature Genetics|October 8, 2024
GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementiaLincoln M P Shade, Yuriko Katsumata, Erin L Abner, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2022
Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among womenJaeyoon Chung, Anjali Das, Xinyu Sun, et al.Acta Neuropathologica|November 28, 2017
Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau depositionChin Hong Tan, Chun Chieh Fan, Elizabeth C Mormino, et al.The Lancet. Neurology|April 9, 2008
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisVivianna M Van Deerlin, James B Leverenz, Lynn M Bekris, et al.Human Molecular Genetics|October 1, 2005
High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsyRosa Rademakers, Stacey Melquist, Marc Cruts, et al.Nature Genetics|August 4, 2014
A framework for the interpretation of de novo mutation in human diseaseKaitlin E Samocha, Elise B Robinson, Stephan J Sanders, et al.Neurology. Genetics|May 28, 2016
ABCA7 frameshift deletion associated with Alzheimer disease in African AmericansHolly N Cukier, Brian W Kunkle, Badri N Vardarajan, et al.Archives of Neurology|February 10, 2010
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegenerationChang-En Yu, Thomas D Bird, Lynn M Bekris, et al.Pageof 30